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The pathways leading to female sexual determination in mammals are incompletely defined. Loss-of-function mutations
in the WNT4 gene appear to cause developmental abnormalities of sexual differentiation in women and mice. We
recruited six patients with different degrees of Müllerian abnormalities, with or without renal aberrations and a nor-
mal female 46,XX karyotype. A clear androgen excess was found only in one patient. This 19-year-old woman was
affected by primary amenorrhoea, absence of Müllerian ducts derivatives, clinical (acne and hirsutism) and biochem-
ical (repeatedly high levels of testosterone) signs of androgen excess. Direct sequencing of her WNT4 gene followed by
functional studies in human ovarian cells (OVCAR3) was performed. This patient carried the novel R83C loss-
of-function dominant negative mutation in her WNT4, confirming the role of WNT4 in the development and mainte-
nance of the female phenotype in women. Our study can also help refine the phenotype of WNT4 deficiency in
humans. In fact, it appears that at least in this limited casuistic small group of patients, the absence of a uterus (and
not other Müllerian abnormalities) and the androgen excess are the pathognomonic signs of WNT4 defects, suggest-
ing that this might be a clinical entity distinct from the classic Mayer–Rokitansky–Kuster–Hauser syndrome.
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Introduction
Differentiation of a testis or an ovary from the bipotential
gonad is a complex developmental process involving various
genes and hormones (MacLaughlin and Donahoe, 2004). This
is the primary step in sex determination in mammals, including
humans. Several genes have been identified as being essential
for the early steps of sexual development in males and females
(Luo et al., 1994; Miyamoto et al., 1997; Katoh-Fukui et al.,
1998; Birk et al., 2000; Hammes et al., 2001). Factors involved
in male sex differentiation are well studied, whereas the
pathways that regulate female sexual differentiation remain
incompletely defined. Wnt4, one of a few factors with a dem-
onstrated function in the ovarian determination pathway, has
been implicated in sex differentiation in mice (Vainio et al.,
1999; Jeays-Ward et al., 2004). Wnt4, a secreted protein that
acts as a repressor of the male differentiation (Jordan et al.,
2001; Jeays-Ward et al., 2003), is a member of the Wnt family
of secreted molecules that function in a paracrine manner to
effect several developmental changes. Wnts bind to members
of the Frizzled family of cell surface receptors and activate a
cascade of intracellular signals leading to the transcriptional
activation of target genes. The pathway downstream WNT4
operates via follistatin, and it has both anti-testis (inhibition of
the coelomic vessels) and pro-ovary function (support of germ
cells) (Yao et al., 2004). The role of WNT4 in female sexual
differentiation was confirmed in humans by the description of
a loss-of-function mutation in WNT4 gene causing develop-
mental abnormalities of sexual differentiation in women
(Biason-Lauber et al., 2004). To corroborate the role of WNT4
in sexual determination in women and to better define the clin-
ical phenotype of WNT4 deficiency, we looked for mutations
in the WNT4 gene in a limited cohort of 46,XX patients
affected by abnormalities of Müllerian ducts with or without
renal and gonadal involvement.
Patients and methods
Case report
Six patients (age 6 months to 20 years) with different degrees of
Müllerian abnormalities (uterine agenesis n = 4 and uterus didelphys,
i.e. double uterus with double cervix and double vagina, caused by a
failure of the Müllerian ducts to unite n = 2), without (n = 2) or with
renal abnormalities (n = 4: renal agenesis n = 2 / 4; renal dysplasia n =
2/4). Their karyotype was 46,XX. A clear androgen excess was found
only in one patient. This 19.5-year-old woman was referred for pri-
mary amenorrhoea and dysmorphic features. She was the seventh
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child of apparently unrelated parents (father 38 and mother 42 years
old) and had two healthy sisters (one with two children) and a brother
with behavioural problems. One sister died at 5 months of age and two
twins shortly after birth for unspecified reasons (Figure 1). Adrenarche
occurred at 10 years, thelarche 1 year later. Breast and pubic-hair
development progressed normally (Tanner stage 5). At physical
examination, she was obese and short (69.2 kg; 148.6 cm; BMI
31.59 kg/m2) with dysmorphic features (anterior hairline, bushy
Figure 1. (A) Family tree and DNA sequence chromatograms obtained by direct sequencing of PCR products showing the presence of the heter-
ozygote C to T substitution in exon 2, not present in normal individuals (control, representative example out of 100, 200 alleles). (B) General
structure of the WNT4 gene and protein and location of the R83C mutation. The genomic organization is derived from the published sequences
(Accession number NT_004610). The protein domains were identified using the ELM server. (C) Sequence alignment of human, rat, mouse,
zebrafish and drosophila WNT4 proteins, showing the conserved R83 mutated in our patient. Alignments were performed using the CLUSTALW
algorithm. nd, not done; WT, wild type.
A.Biason-Lauber et al.
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eyebrows and synophrys, short philtrum, high palate, prominent ears,
short neck, brachidactyly, cubitus valgus and broad chest). Signs of
androgen excess included acne on the forehead and on the chest and
mild facial hirsutism. The clitoral size was normal, but the vaginal
introitus was small and short (0.7 cm). Her total testosterone was
repeatedly elevated (up to 6.86 nmol/l, normal range 0.3–3.4). An
extensive hormonal work-up showed normal levels of androstenedi-
one (8.53 nmol/l, normal range 1.4–8.9), dehydroepiandrosterone
sulphate (5 μmol/l, normal range 2.2–9), luteinizing hormone
(5.3 IU/l, normal range 4.5–25), FSH (4.5 IU/l, normal range 4–20),
17-hydroxyprogesterone (7.2 nmol/l, normal range 0.5–9.5), proges-
terone (1.92 nmol/l, normal range 1–64) and estradiol (216 pmol/l,
normal range 76–1285).
Chromosomal analysis of 20 cells showed normal female 46,XX
karyotype, and SRY was absent in lymphocytes.
Pelvic ultrasonography showed uterine agenesis, normal-sized
gonads (20 × 20 mm) but with anomalous location and a pattern of
solid tissue on the left gonad that failed to show any follicular struc-
ture also on magnetic resonance imaging. The kidneys were normal in
size (left 114 × 50 mm; right 112 × 40 mm) and location. This clini-
cal picture has important similarity to that of our previously described
patient (Biason-Lauber et al., 2004).
Genomic DNA mutational analysis and expression studies
After obtaining informed consent, genomic DNA was extracted,
amplified and sequenced as previously described (Biason-Lauber et al.,
2004) from peripheral blood leukocytes of the patients, of the family
members (when available) as well as of 100 normal ethnically
matched controls (200 alleles; male : female = 1:1). To study the
functional implications of the mutation, we expressed wild-type (WT)
and mutant WNT cDNA in human ovarian adenocarcinoma
NIH:OVCAR3 (ATCC HTB-161) and analysed the influence of
WNT4 variants on steroidogenic enzyme expression and activity as
previously published (Biason-Lauber et al., 2004).
Immunofluorescence
To distinguish wild-type and mutant WNT4, the wild-type protein was
myc-tagged, whereas the mutant protein was Xpress-tagged. OVCAR3
cells were grown on glass coverslips and transfected with the wild-type
(myc-tagged) or mutant (Xpress-tagged) WNT4 cDNA. Forty-eight
hours after transfection, the cells were fixed for 10 min in methanol at
–20°C and blocked for unspecific binding in PBS containing 0.5% milk
powder for 30 min at room temperature. The cells were incubated with
an antibody against the myc epitope (9E10, dilution 1:100) or with anti-
Xpress for 60 min at room temperature followed by an anti-mouse
Cy3- and FITC-conjugated secondary antibody (Jackson Immuno
Research, dilution 1:200) for 60 min. Nuclei were stained in a
1:10 000 dilution of Hoechst stock solution. Coverslips were mounted
on glass plates, embedded in Kaiser’s glycerol gelatin for microscopy
(Merck) and examined using a Zeiss Axioskop microscope.
In vivo labelling of WNT4 with tritiated palmitate was performed
as described previously (Willert et al., 2003), and the assay was
performed in cell extract after immunoprecipitation of the trans-
fected WNT4 using anti-Xpress antibodies (Biason-Lauber et al.,
2004). The amounts of β-catenin in cell lysates were quantified
using the Human Total β-catenin DuoSet IC ELISA (R&D Sys-
tems) as suggested by the provider. The already described E226G
mutation (Biason-Lauber et al., 2004) was used as internal control
in all assays.
The study conformed to the guidelines of the institutional review
board.
Results and discussion
The WNT4 gene of the patient carried a heterozygote single-
base exchange (C to T) in exon 2 of the WNT4 gene correspond-
ing to an Arg83Cys (R83C) mutation in the WNT4 protein
(Figure 1A,B). The absence of the mutation in the DNA of the
mother, the siblings and 100 normal controls (Figure 1A) indi-
cates that this substitution was either inherited from the father
(whose DNA was not available) or a de novo event and that it is
not a common polymorphism. The WNT4 genes of the other
five patients did not carry any mutation in the coding region or
in intron/exon boundaries. None of the six subjects had muta-
tions in the TCF2 gene, which encodes the transcription factor
HNF1β, crucial for Müllerian ducts, kidney and pancreas devel-
opment (Lindner et al., 1999).
The mutated Arg 83 is conserved among Wnt4 members
(Figure 1C). Because WNT4 is known to repress male-specific
genes, including the steroidogenic enzymes CYP17A1 and
HSB3B2 (essential for the synthesis of testosterone) (Vainio
et al., 1999), it is to be expected that an inactive WNT4 would
fail to do so. As a consequence, expression and activity of
these enzymes would be higher with increased androgen syn-
thesis. Accordingly, functional studies showed that the mutated
WNT4 does not suppress the expression of the androgen-
synthetic enzymes CYP17A1 and HSD3B2 in human ovarian
cells, indicating again a loss-of-function mutation (Figure 2A,B).
The ‘escape’ of the expression of steroidogenic enzymes from
WNT4 control results in an increase of testosterone production
in OVCAR3 cells transfected with the mutated WNT4 (Figure
2C), as it appears to be the case in the ovaries of our patient.
The fact that transfection of WT WNT4 does not significantly
change message and activity of the steroidogenic enzymes
indicates that, in basal conditions, overexpression of normal
WNT4 does not override the effect of the endogenous WNT4
in this system and indicates a possible limitation of this in vitro
assay. The mutated WNT4 has dominant negative properties,
providing a clear genotype–phenotype correlation.
According to the most accepted view, WNT-secreted pro-
teins bind to the Frizzled family of receptors and start at least
three different intracellular pathways, resulting in the regula-
tion of gene expression and/or changes in cell behaviour. The
canonical pathway involves a co-receptor from the low-density
lipoprotein receptor family and results in stabilization of intra-
cellular β-catenin. β-Catenin is a multifunctional protein that
can act as a transcriptional regulator upon entering the nucleus.
However, it is rapidly degraded by ubiquitination after phos-
phorylation by a complex consisting of APC and axin, which
facilitate the phosphorylation of β-catenin by casein kinase 1
and then glycogen synthase kinase 3. Binding of WNT proteins
to the surface receptor(s) leads to activation of the protein that
when dishevelled in turn inactivates the destruction complex,
allowing β-catenin to accumulate in the cytoplasm and enter
the nucleus. In the absence of WNT4 binding, the stabilization
of β-catenin will not take place, resulting in the alteration of
target gene expression (Hsieh, 2004).
The mutant WNT4 of our patient could not be secreted
(Figure 3A), although it was normally produced (Figure 3A)
and lipid-modified (Figure 3B). Although staining for the
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wild-type protein can be detected inside and outside trans-
fected OVCAR3 cells (Figure 4A), the mutated WNT4 was
detectable only in the cytoplasm of transfected cells (Figure
4B) and appears to block the wild type from exiting the cells
(Figure 4C), thus preventing any activation of the receptors
and therefore impairing the WNT4-dependent signal.
The demonstration that the mutation causes indeed a defect in
the WNT4 signal transduction pathway is given by the detection
of very low amounts of β-catenin (stabilized by the activation of
Wnt pathway) in OVCAR3 cells transfected with the mutant
WNT4 (Figure 3C). Although the attachment of lipid to the
mutated WNT4 seems to be normal, a substitution of an arginine
for a cysteine will probably lead to misfolded protein, because
one extra cysteine may promote the formation of illegitimate
Figure 2. The R83C-mutated WNT4 is unable to suppress the
expression and activity of steroidogenic enzymes in the ovarian aden-
ocarcinoma cell line (OVCAR3). (A) Quantification by RT–PCR of
the expression of the steroidogenic enzymes 17α-hydroxylase
(CYP17A1) and 3β-hydroxysteroid dehydrogenase 2 (HSD3B2) in
the absence (–) or presence of transfection of normal (WT), mutant
(R83C) WNT4 cDNA and 1:1 combination of the two. Results are
expressed as relative increase in transfected cells as compared with
untransfected cells. Panel B shows the results of the qualitative reverse-
transcriptase PCR experiments. Glyceraldehyde-3-phosphatedehydro-
genase (GAPDH), a protein expressed in most tissues, was used as
internal control. (C) Testosterone levels in cell culture medium from
OVCAR3 cells untransfected or transfected with R83C mutant, wild
type (WT), a combination of the two (R83C + WT), and E226G
mutant WNT4 as reference are shown. The results are means ± SD
derived from three independent experiments. P-values were calculated
using the paired t-test. Non-significant P-values are not indicated.
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Figure 3. (A) Western blot analysis of WNT4 from the cell culture
medium and the cell extract of OVCAR3 cells after transfection with
R83C mutant, wild-type (WT) WNT4 cDNA or an equimolar ratio of
the two, using the anti Xpress antibody recognizing only the trans-
fected human WNT4. The mutated protein is not secreted, but the
loss-of-function is not because of decreased protein amount or stabil-
ity. (B) The mutated R83C WNT4 protein appears to be normally
lipid-modified. In vivo labelling of WNT4 with tritiated palmitate is
shown. WNT4 was partially purified from cell extracts of OVCAR3
cells transfected with R83C mutant, wild type (WT), a combination of
the two (R83C + WT), and E226G mutant WNT4 as reference, then
treated with 3H palmitate for 5 h and immunoprecipitated. (C) The
WNT signalling pathway is impaired in cells expressing the mutated
WNT4. Amounts of β-catenin from OVCAR3 cells untransfected or
transfected with WNT4 variants as described in A are depicted. The
decreased amounts of measurable β-catenin in cell transfected with
the mutant WNT4 alone or in combination with an equimolar amount
of wild-type protein suggest that the signalling pathway is weakened
and that the mutant WNT4 has dominant negative properties.
A.Biason-Lauber et al.
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disulphide bonds and misfolding. Misfolded proteins are usually
retained in the endoplasmic reticulum (ER), cannot be secreted
and do not activate their signalling pathway. Misfolded proteins
can be targeted to the degradation pathway but can also escape
this protective mechanism and form intractable aggregates. The
importance of such phenomenon is demonstrated by the increas-
ing number of pathologies associated with the deposition of such
aggregates in tissues (Dobson, 2004). In this view, a possible
explanation of the lack of secretion of the wild-type WNT4 pro-
tein in the presence of its mutant counterpart might be the ‘trap-
ping’ of the wild-type protein in such deposits, although a seeding
(analogue to prion proteins, Jarrett and Lansbury, 1993; Prusiner,
1997) or cross-seeding (analogue to amyloid β-protein, Lund-
mark et al., 2005; Yamamoto et al., 2005) cannot not excluded.
This second loss-of-function mutation in WNT4 gene causing
developmental abnormalities in humans confirms the role of
WNT4 as a major player in the development and maintenance of
the female phenotype in women. This study can also help refine
the phenotype of WNT4 deficiency in humans. In fact, it seems
that, at least in this limited casuistic group of patients, the absence
of uterus (and not other Müllerian abnormalities) and the andro-
gen excess are the pathognomonic signs of WNT4 defects, sug-
gesting that WNT4 deficiency might be a clinical entity distinct
from the typical Mayer–Rokitansky–Kuster–Hauser syndrome,
also in view of recent work excluding WNT4 mutations in the
classical form of the syndrome (Clement-Ziza et al., 2005).
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